IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate-Reference-Cited by-同舟云学术

IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate

Published:2019-12-11 Issue:4 Volume:35 Page:663-672
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Takano Keiko¹^ORCID,Saeki Chisato¹^ORCID,Oikawa Tsunekazu¹^ORCID,Hidaka Akihisa¹^ORCID,Mizuno Yusuke¹^ORCID,Ishida Jinya¹^ORCID,Takakura Kazuki¹^ORCID,Nakano Masanori¹^ORCID,Torisu Yuichi¹^ORCID,Amano Katsushi¹^ORCID,Ishikawa Tomohisa¹^ORCID,Zeniya Mikio²^ORCID,Tsubota Akihito³^ORCID,Saruta Masayuki¹^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Internal MedicineThe Jikei University School of Medicine Tokyo Japan

2. Gastroenterology, Sanno Medical CenterInternational University of Health and Welfare Tokyo Japan

3. Core Research Facilities, Research Center for Medical ScienceThe Jikei University School of Medicine Tokyo Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.14900

Reference35 articles.

1. Primary Biliary Cirrhosis: The Molecule and the Mimic

2. Primary Biliary Cirrhosis

3. Autoreactive T-Cell Responses in Primary Biliary Cirrhosis Are Proinflammatory Whereas Those of Controls Are Regulatory

4. B cells and autoimmune liver diseases

5. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship between CXCR6+CD8+T cells and clinicopathological parameters in patients with primary biliary cholangitis;Hepatology International;2024-08-12

2. The treatment of primary biliary cholangitis: from shadow to light;Therapeutic Advances in Gastroenterology;2024-01

3. Gut microbial profile of treatment-naive patients with primary biliary cholangitis;Frontiers in Immunology;2023-05-08

4. Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis;Frontiers in Immunology;2022-07-08

5. Imbalanced distribution of group 2 innate lymphoid cells (ILCs) and ILC precursors in peripheral blood of patients with primary biliary cholangitis;Scandinavian Journal of Immunology;2022-04-03